Skip to main content
GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.2270
+0.0010 (0.44%)
Apr 1, 2025, 12:49 PM CET

GenSight Biologics Revenue

In the year 2024, GenSight Biologics had annual revenue of 2.63M EUR, down -11.44%. GenSight Biologics had revenue of 897.00K in the half year ending December 31, 2024, with 46.09% growth.

Revenue
2.63M
Revenue Growth
-11.44%
P/S Ratio
8.25
Revenue / Employee
238.64K
Employees
16
Market Cap
28.97M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.63M-339.00K-11.44%
Dec 31, 20232.96M-1.90M-39.08%
Dec 31, 20224.87M-2.84M-36.89%
Dec 31, 20217.71M269.00K3.62%
Dec 31, 20207.44M2.53M51.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sanofi 44.29B
EssilorLuxottica Société anonyme 26.51B
Sartorius Stedim Biotech 2.78B
bioMérieux 3.98B
Eurofins Scientific SE 6.95B
Ipsen 3.57B
Virbac 1.40B
emeis Société anonyme 5.43B
Revenue Rankings

GenSight Biologics News

More News